Given that SRC‐1 downregulation led to a decrease in HCC cell invasiveness both in vitro and in vivo, inhibiting SRC‐1 emerges as a potentially effective strategy for controlling HCC metastasis. This evidence concerns the gene SRC and hepatocellular carcinoma.